Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
Paul E. Hanna, Qiyu Wang, Ian Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L. Reynolds, Shruti Gupta, David E. Leaf, View ORCID ProfileMeghan E. Sise
doi: https://doi.org/10.1101/2023.01.18.23284656
Paul E. Hanna
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MD MScQiyu Wang
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MDIan Strohbehn
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
BADaiana Moreno
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
BSDestiny Harden
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
BATianqi Ouyang
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MPHNurit Katz-Agranov
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MDHarish Seethapathy
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MBBSKerry L. Reynolds
2Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MDShruti Gupta
3Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MA
4Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, MA
MD MPHDavid E. Leaf
3Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MA
MD MMScMeghan E. Sise
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA
MD MSData Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 18, 2023.
Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
Paul E. Hanna, Qiyu Wang, Ian Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L. Reynolds, Shruti Gupta, David E. Leaf, Meghan E. Sise
medRxiv 2023.01.18.23284656; doi: https://doi.org/10.1101/2023.01.18.23284656
Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
Paul E. Hanna, Qiyu Wang, Ian Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L. Reynolds, Shruti Gupta, David E. Leaf, Meghan E. Sise
medRxiv 2023.01.18.23284656; doi: https://doi.org/10.1101/2023.01.18.23284656
Subject Area
Subject Areas
- Addiction Medicine (326)
- Allergy and Immunology (642)
- Anesthesia (170)
- Cardiovascular Medicine (2452)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11895)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3827)
- Geriatric Medicine (356)
- Health Economics (646)
- Health Informatics (2469)
- Health Policy (954)
- Hematology (348)
- HIV/AIDS (806)
- Medical Education (379)
- Medical Ethics (105)
- Nephrology (409)
- Neurology (3595)
- Nursing (202)
- Nutrition (536)
- Oncology (1865)
- Ophthalmology (544)
- Orthopedics (227)
- Otolaryngology (293)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (457)
- Pediatrics (1057)
- Primary Care Research (432)
- Public and Global Health (6257)
- Radiology and Imaging (1317)
- Respiratory Medicine (842)
- Rheumatology (387)
- Sports Medicine (332)
- Surgery (417)
- Toxicology (51)
- Transplantation (177)
- Urology (149)